{"ModuleTitle": "Company Description", "CompanyName": "Horizon Therapeutics Public Limited Company", "Symbol": "HZNP", "Address": "CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD, DUBLIN, 4, Ireland", "Phone": "011-353-1-772-2100", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "Europe", "CompanyDescription": "Unless otherwise indicated or the context otherwise requires, references to the\r\n\"Company\", \"we\", \"us\" and \"our\" refer to Horizon Therapeutics plc (formerly\r\nknown as Horizon Pharma plc) and its consolidated subsidiaries.\r\n\r\nOverview\r\n\r\nWe are focused on researching, developing and commercializing medicines that\r\naddress critical needs for people impacted by rare and rheumatic diseases. Our\r\npipeline is purposeful: we apply scientific expertise and courage to bring\r\nclinically meaningful therapies to patients. We believe science and compassion\r\nmust work together to transform lives.\r\n\r\n\r\n                                       1\r\n\r\n--------------------------------------------------------------------------------\r\nOur Strategy\r\n\r\nHorizon today is a leading biopharma company focused on rare diseases,\r\ndelivering innovative therapies to patients and generating value for our\r\nshareholders.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f02%2f26%2f0001564590-20-006575.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Andy Pasternak", "title": "Chief Business Officer & Executive Vice President"}, {"name": "Jeffrey D. Kent", "title": "Executive VP-Medical Affairs & Outcomes Research"}, {"name": "Jeffrey W. Sherman", "title": "Chief Medical Officer & Executive Vice President"}, {"name": "Paul W. Hoelscher", "title": "Chief Financial Officer & Executive Vice President"}, {"name": "Timothy P. Walbert", "title": "Chairman, President & Chief Executive Officer"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}